Indica Labs achieves CE-IVD certification for AI-based Prostate Cancer Detection and Gleason Grading Tool
Indica Labs, the leading provider of computational pathology software and services, is excited to an...
Paige AI Solution for Prostate Cancer Biomarker Detection Receives CE-IVD and UKCA Marks
First European regulatory clearance for Paige’s digital biomarker capabilities May 12, 2022 10:05 AM...
Using AI to detect cancer from patient data securely
A new way of using artificial intelligence to predict cancer from patient data without putting perso...
New Artificial Intelligence Algorithm Improves The 3D Prediction Of Prostate Cancer
The use of artificial intelligence (AI) to diagnose cancer and distinguish prostate cancers from ben...
Ultivue Announces Co-Marketing and Co-Development Collaboration with Paige for AI-Powered Biomarker Imaging Solutions for Precision Medicine
Ultivue, an industry leader in multiplexing tools for tissue biomarker analysis, and Paige, the glob...
Paige Earns CE-IVD and UKCA Marks for Clinical AI Application to Detect Breast Cancer Metastases in Lymph Nodes
Paige, a global leader in clinical AI applications in pathology, today announced it received CE-IVD...
![PaigeBLN_PressRelease[2]](https://www.pathologynews.com/wp-content/uploads/2022/03/PaigeBLN_PressRelease2-727x393.jpg)
Paige Launches AI Software to Enable Accurate and Efficient Detection of Breast Cancer Metastases in Lymph Nodes
NEW YORK–(BUSINESS WIRE)–Paige, the global leader in AI-based diagnostic software in pathology, toda...
‘Off label’ use of imaging databases could lead to bias in AI algorithms
Significant advances in artificial intelligence (AI) over the past decade have relied upon extensive...